Figure 3.
Growth inhibition assay. Dasatinib showed minimal to modest activity against leiomyosarcoma cell lines. Maximal growth inhibitory effect for SK-UT-1 and SK-UT-1B was 42.8% and 55% respectively.
Growth inhibition assay. Dasatinib showed minimal to modest activity against leiomyosarcoma cell lines. Maximal growth inhibitory effect for SK-UT-1 and SK-UT-1B was 42.8% and 55% respectively.